Previous close | 0.4500 |
Open | 0.3500 |
Bid | 0.0000 |
Ask | 0.5000 |
Strike | 25.00 |
Expiry date | 2024-07-19 |
Day's range | 0.2600 - 0.4500 |
Contract range | N/A |
Volume | |
Open interest | 90 |
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
When we're researching a company, it's sometimes hard to find the warning signs, but there are some financial metrics...
Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, today received from S&P Global, a leading rating agency, the change of its rating outlook to stable from negative (bbb-, stable outlook). Moody's changed the credit rating outlook from negative to stable on May 17 (baa3, stable outlook).